Keywords: novartis, exelon, gets, positive, opinion, eu, cmph

Novartis' Exelon gets positive opinion from the EU's CMPH, hopeful of 2006 approval

Article | 06 February 2006

Print This

Swiss drug major Novartis has received a positive opinion from Europe's Committee for Medicinal Products for Human Use recommending that, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in